GB974625A - Injectable pharmaceutical emulsion vehicles - Google Patents

Injectable pharmaceutical emulsion vehicles

Info

Publication number
GB974625A
GB974625A GB29950/61A GB2995061A GB974625A GB 974625 A GB974625 A GB 974625A GB 29950/61 A GB29950/61 A GB 29950/61A GB 2995061 A GB2995061 A GB 2995061A GB 974625 A GB974625 A GB 974625A
Authority
GB
United Kingdom
Prior art keywords
viruses
influenza
derived
pollens
venoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB29950/61A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB974625A publication Critical patent/GB974625A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB29950/61A 1960-09-06 1961-08-18 Injectable pharmaceutical emulsion vehicles Expired GB974625A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5393160A 1960-09-06 1960-09-06

Publications (1)

Publication Number Publication Date
GB974625A true GB974625A (en) 1964-11-11

Family

ID=21987534

Family Applications (1)

Application Number Title Priority Date Filing Date
GB29950/61A Expired GB974625A (en) 1960-09-06 1961-08-18 Injectable pharmaceutical emulsion vehicles

Country Status (4)

Country Link
CH (1) CH413237A (enExample)
FR (1) FR4690M (enExample)
GB (1) GB974625A (enExample)
NL (1) NL269002A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158054A (en) 1973-10-18 1979-06-12 Duncan Flockhart & Co. Ltd. Preparation of virus sub-unit vaccines
FR2443873A1 (fr) * 1978-12-14 1980-07-11 Kao Corp Nouvelle composition emulsifiante pour la production et la stabilisation d'emulsions du type eau-dans-huile
GB2170708A (en) * 1985-02-10 1986-08-13 Israel State Injectable vaccine system
USRE32393E (en) * 1967-09-01 1987-04-07 Kabivitrum Ab Composition for enhancing the administration of pharmacologically active agents

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH662944A5 (it) * 1984-10-18 1987-11-13 Pier Luigi Prof Dr Luisi Procedimento per la preparazione di biocompatibili di micelle inverse di biocompatibili e loro utilizzazione.
DE3446515A1 (de) * 1984-12-20 1986-06-26 Behringwerke Ag, 3550 Marburg Oeladjuvierte vaccine und verfahren zu ihrer herstellung
FR2702373B1 (fr) * 1993-03-08 1996-06-07 Rhone Merieux Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.
FR2702374B1 (fr) * 1993-03-08 1995-04-14 Rhone Merieux Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32393E (en) * 1967-09-01 1987-04-07 Kabivitrum Ab Composition for enhancing the administration of pharmacologically active agents
US4158054A (en) 1973-10-18 1979-06-12 Duncan Flockhart & Co. Ltd. Preparation of virus sub-unit vaccines
FR2443873A1 (fr) * 1978-12-14 1980-07-11 Kao Corp Nouvelle composition emulsifiante pour la production et la stabilisation d'emulsions du type eau-dans-huile
GB2170708A (en) * 1985-02-10 1986-08-13 Israel State Injectable vaccine system

Also Published As

Publication number Publication date
NL269002A (enExample)
CH413237A (de) 1966-05-15
FR4690M (enExample) 1966-12-26

Similar Documents

Publication Publication Date Title
GB974625A (en) Injectable pharmaceutical emulsion vehicles
US3983228A (en) Water-in-oil adjuvant composition
CA1147722A (en) Immunologic adjuvant
EP0007277B1 (en) New glycolipid compound useful as immunologic adjuvant and its preparation
DE3911442A1 (de) Impfstoff-praeparation
JP2004536785A5 (enExample)
DE2141289A1 (de) Spray-Vakzinen
Masurel Serological characteristics of a” new” serotype of influenza A virus: the Hong Kong strain
EP0023865A2 (en) New glycolipid compounds, process for preparation and use as immunological adjuvant
EP0028196B1 (en) Glycolipid derivatives, their preparation and compositions comprising them
DK0784486T3 (da) Interleukin-12 som en adjuvans til Paramyxoviridae-vacciner
JPS6225646B2 (enExample)
CN107469075A (zh) 一种高剂量四价流感疫苗组合物
Yoshikawa et al. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase
Eidson et al. Vaccination of chickens with a clone-selected Lastoa strain of Newcastle disease virus
DE69120761T2 (de) Vakzinale Zusammensetzung gegen infektiöse Pathogene
Woodhour et al. Respiratory virus vaccines: IV. Heptavalent Respiratory Syncytial-parainfluenza-mycoplasma-influenza vaccine in institutionalized persons
US2720484A (en) Process for separation of viral substances from animal tissues
CN209858515U (zh) 一种检测室内甲醛含量的新型设备
RU2068271C1 (ru) Аттенуированный холодоадаптированный штамм вируса гриппа в/ленинград/14/17/55 для получения штаммов живой гриппозной вакцины
Kucera et al. Studies on the antigenicity of an inactivated, aluminum hydroxide adjuvant equine influenza vaccine
Lang Balija et al. Mumps virus infection of guinea pigs
Woods et al. A controlled field study using live virus vaccines and an antiserum in a preconditioning program
EP4630051A1 (en) Vaccine for vaccinating a canine
Lew et al. Development and preliminary testing of an inactivated equine adenovirus vaccine